First of its kind study on the value of Canada’s specialty drug marketNeighbourhood Pharmacies and IQVIA team up to provide quantitative data report on the real value of pharmacy specialty services. Follicular lymphoma: 6-year follow-up of the RELEVANCE trialA recent study found the drug combination lenalidomide + rituximab is a durable, effective and safe alternative to the standard regimen combining rituximab and chemotherapy. One-stop shop: New Canadian cardiovascular disease guideline pulls together dozens of recommendations The guideline is an update to a 2018 iteration and adds 48 fresh recommendations. Vitamins A, C and E may cut risk of glaucoma by half Study from Spain finds a 47% reduced risk over time. Kidney cancer: a new indication approved for Keytruda The treatment is approved for patients who have a moderate to high risk of recurrence, following nephrectomy or nephrectomy accompanied by surgical resection of metastatic lesions. How to prevent missing person incidents for seniors living with dementia People living with dementia are at risk of getting lost, and go missing every day in Canada. Poll: Do patients call you by the first name? Are you fine with that? Take our weekly doctor poll. See what your colleagues say. How does an N95 respirator actually work to protect the wearer? While souped-up masks are everywhere these days, what's the physics behind the additional protection an N95 provides? Mindfulness worked as well for anxiety as drug in study The study tested a widely used mindfulness program that includes 2 1/2 hours of classes weekly and 45 minutes of daily practice at home. New treatment approved for CKD associated with type 2 diabetes Health Canada approves adjunct treatment for chronic kidney disease based on two trial results. First Previous 131 132 133 134 135 Next Last
